Nicotine Pouches and Exercise

Nicotine pouches are increasingly common among people who exercise regularly, including athletes, gym-goers, and recreational runners. The overlap is not surprising: nicotine is a stimulant, exercise communities have a culture of performance optimization, and pouches are discreet enough to use during a workout. The pharmacology of nicotine interacts with the physiology of exercise in specific ways that are worth understanding, because the combination changes the cardiovascular math in ways that are not immediately obvious.

What nicotine does during exercise

At rest, nicotine increases heart rate by 10 to 20 beats per minute and raises blood pressure by 5 to 10 mmHg through sympathetic nervous system activation [2] [5]. These are well-established acute effects that occur with each dose of nicotine, even in tolerant users, though the magnitude is smaller in chronic users than in first-time users. During exercise, these effects are additive.

If your exercise heart rate at a given intensity would be 150 bpm, using a nicotine pouch might push it to 160 to 170 bpm. If your resting blood pressure would rise from 120/80 to 160/90 during exercise, nicotine may push it to 170/100 or higher. The nicotine effect and the exercise effect stack because both operate through sympathetic activation: exercise increases sympathetic output to meet the metabolic demands of working muscles, and nicotine stimulates sympathetic outflow through its action on nicotinic receptors in the autonomic ganglia and the adrenal medulla.

This stacking increases myocardial oxygen demand. The heart is working harder (faster rate, higher pressure) and consuming more oxygen. In a healthy heart with normal coronary arteries, this additional demand is met without difficulty. The coronary arteries dilate in response to increased demand, and the heart receives the oxygen it needs. In a heart with coronary artery disease, the narrowed arteries may not be able to increase oxygen supply to match the increased demand, creating a supply-demand mismatch that can trigger ischemia [2]. This is the primary acute risk of combining nicotine with exercise: not a risk for the general population of healthy exercisers, but a meaningful one for the subset of people with coronary disease, which includes many people who do not know they have it.

Nicotine also affects the blood itself during exercise. It increases platelet aggregation, making blood slightly more prone to clotting, and it reduces the compliance of arterial walls, meaning the vessels are less able to expand and absorb the pulsatile pressure of each heartbeat [2]. During vigorous exercise, when cardiac output may be five to six times its resting value, these vascular effects are layered onto an already-stressed circulatory system. Again, for most healthy people this is clinically insignificant. For people with atherosclerotic plaques or other vascular vulnerabilities, the additional stress may matter.

Performance effects

The evidence for nicotine improving athletic performance is modest and task-specific [1] [4].

What nicotine may improve:

• Reaction time. The stimulant effect of nicotine consistently improves reaction time in controlled studies. The effect size is small but reproducible, on the order of 5% to 10% faster responses. This could be relevant in sports requiring fast responses, such as fencing, boxing, or racquet sports.
• Alertness and concentration. Nicotine improves sustained attention, which may benefit performance in endurance events or sports requiring prolonged focus. This is the effect that many athletes report seeking: not a physical edge, but the ability to stay mentally engaged during long training sessions or late-game situations.
• Fine motor control. Some evidence suggests nicotine may improve fine motor precision, relevant to sports like shooting or archery [4]. This is the effect that initially drew WADA’s attention.

What nicotine does not improve:

• Aerobic capacity (VO2 max). Nicotine does not increase the body’s ability to transport or use oxygen during exercise [3]. The cardiovascular stimulation increases heart rate but does not improve the efficiency of oxygen extraction by working muscles.
• Muscular strength or power. No meaningful ergogenic effect on force production has been demonstrated.
• Endurance time to exhaustion. One controlled trial found no improvement in time-trial cycling performance with transdermal nicotine [3]. The study used nicotine patches on non-smokers and measured both time-trial performance and time to exhaustion, finding no significant improvement in either.

The net effect is that nicotine is a cognitive enhancer, not a physical performance enhancer. Athletes who use it are typically seeking the alertness and focus effects, not a direct physical advantage. Whether these modest cognitive benefits justify the cost of nicotine dependence is a calculation that the pharmacology cannot make for you.

Heart rate zone implications

Many people train using heart rate zones derived from their maximum or resting heart rate. Nicotine complicates this by elevating heart rate at every intensity level.

If you normally train in a zone of 140 to 160 bpm, using a nicotine pouch during training may shift your actual physiological effort into a zone equivalent to 130 to 150 bpm at the displayed heart rate. You would reach your target zone number at a lower true exercise intensity, and you might hit your maximum heart rate alarm while doing less actual work than usual. The result is that heart-rate-based training with nicotine on board tends to underestimate your available capacity: you stop or slow down at a given heart rate that, without nicotine, you could sustain at a higher workload.

For competitive athletes or anyone training seriously, this introduces a systematic bias into heart-rate-guided sessions. The options are to establish separate zone calculations for nicotine and non-nicotine sessions, to account for the offset (roughly 10 to 15 bpm in tolerant users, higher in new users), or to remove the pouch before training and establish your zones without nicotine. The last option is the cleanest from a training-methodology standpoint, though it requires a period of abstinence during training that some dependent users find difficult.

Rating of perceived exertion (RPE), which relies on subjective effort assessment rather than heart rate measurement, is less affected by nicotine and may be more reliable for pacing during exercise with nicotine on board.

Recovery

Nicotine’s vasoconstrictive effect may have implications for post-exercise recovery. Exercise recovery involves increased blood flow to muscles for nutrient delivery and waste removal. The muscles that just worked need oxygen and glucose to replenish their energy stores and need blood flow to clear metabolic byproducts. Nicotine constricts peripheral blood vessels, potentially reducing this recovery blood flow [5].

The vasoconstrictive effect also applies to the skin, which is the primary thermoregulatory organ during and after exercise. Reduced skin blood flow means reduced ability to dissipate the heat generated during exercise. For most workouts in temperate conditions, this is negligible. In hot environments or during prolonged exercise where thermoregulation is already stressed, the additional vasoconstriction could impair cooling.

Whether these effects are large enough to meaningfully impair recovery or adaptation over time is not well-studied. The pharmacological direction is unfavorable, reduced blood flow to tissues that need more blood flow, but the magnitude of the effect in the context of the much larger exercise-induced vasodilation is unclear. This is one of many areas where the mechanistic reasoning is sound but the clinical data to quantify the impact does not exist.

The WADA position

Nicotine is on the World Anti-Doping Agency’s monitoring list, meaning WADA collects data on its use in sport but does not currently prohibit it [4]. The monitoring program was established because of the prevalence of nicotine use among athletes in certain sports, particularly those requiring precision and reaction time, and the theoretical ergogenic effects on those parameters. Data collected through the monitoring program has shown that nicotine use is higher among athletes in some sports than in the general population, which suggests deliberate use for performance purposes rather than incidental use.

The current evidence has not been sufficient to move nicotine to the prohibited list, primarily because the performance effects are modest, task-specific, and do not clearly constitute an unfair advantage in most sports. The monitoring continues, and the classification could change if stronger evidence of performance enhancement emerges or if the prevalence data suggests a growing problem.

For the recreational athlete or gym-goer who uses nicotine pouches, the WADA classification is largely academic. The relevant question is not whether nicotine confers a competitive edge but whether using pouches during or around exercise poses a health risk that outweighs any perceived benefit. The evidence does not support a clear cardiovascular danger in healthy young adults exercising at moderate intensities, but it also does not provide reassurance for heavy users exercising at high intensities, because that specific combination has not been studied adequately.

What remains unknown

Whether the stacked cardiovascular effects of nicotine and exercise accelerate long-term cardiovascular changes in otherwise healthy athletes. Whether nicotine’s vasoconstrictive effect meaningfully impairs post-exercise recovery or adaptation over months and years of training. Whether the alertness benefits of nicotine during sport carry dependence risks that outweigh the modest performance gains. Whether different exercise intensities interact with nicotine’s hemodynamic effects differently in terms of acute risk. Whether the chronic use pattern typical of nicotine pouch users, who may be absorbing nicotine continuously throughout training and recovery, produces different cardiovascular outcomes than the intermittent nicotine exposure studied in most of the existing exercise research. Each of these questions requires data from populations and durations that the current literature does not cover.

If you have questions about nicotine use and your health, speak with a doctor or pharmacist. The Quitline (1-800-QUIT-NOW) can help with quitting strategies.